Severity predictors for multisystemic inflammatory syndrome in children after SARS-CoV-2 infection in Vietnam

Dien M Tran1,2, Dem V Pham2, Tung V Cao3

  • 1Surgical Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.

Scientific Reports
|July 9, 2024
PubMed

Insights

Identifying predictors for severe Multisystemic Inflammatory Syndrome in Children (MIS-C) is crucial. Lower lymphocyte counts, albumin, and reduced LVEF predict severe MIS-C, aiding early intervention and improved outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Rheumatology

Background:

  • Multisystemic Inflammatory Syndrome in Children (MIS-C) presents with varied severity, from mild symptoms to life-threatening multi-organ dysfunction.
  • Prognostic factors for severe MIS-C outcomes remain incompletely understood, necessitating research into predictive markers.

Purpose of the Study:

  • To identify independent predictors of severe outcomes in children diagnosed with MIS-C.
  • To enhance clinical management strategies by pinpointing high-risk patients early.

Main Methods:

  • A retrospective study analyzed data from 391 children with MIS-C admitted to Vietnam National Children's Hospital between January 2022 and June 2023.
  • Multivariate regression models were employed to determine independent predictors for Pediatric Intensive Care Unit (PICU) admission and shock development.

Main Results:

  • Independent predictors for PICU admission included CRP < 50 mg/L, albumin < 30 g/L, absolute lymphocyte count < 2 × 10^9/L, ferritin ≥ 300 ng/mL, and LVEF < 60%.
  • Shock was associated with decreased absolute lymphocyte count (< 2 × 10^9/L), low albumin (< 30 g/L), and reduced LVEF (< 60%).

Conclusions:

  • Absolute lymphocyte count, serum albumin, C-reactive protein (CRP), and left ventricular ejection fraction (LVEF) are significant independent predictors of MIS-C severity.
  • These findings can guide clinical decision-making for early identification and management of high-risk MIS-C patients to improve prognoses.